Info Sheet

IRB Review Services for Phase I Research

Our dedicated team and processes are built to support your Phase I research needs.

Rely on customized IRB capabilities to ensure appropriate, efficient reviews:

  • Responsive, multi-functional team to ensure service excellence and eliminate delays
  • Real-time access to review status information and approval documents
  • Daily specialized IRB panels to review Phase I research and changes to previously approved research
  • IRB review and approval issued prior to FDA 30-day investigational new drug (IND) wait period

To learn more, fill out the form to download the info sheet.

Who should watch?

text goes here

CEU Credits

text goes here

Certificate of Attendance

text goes here

Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour

Download Now